TRINALIN Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Trinalin, and what generic alternatives are available?

Trinalin is a drug marketed by Schering and is included in one NDA.

The generic ingredient in TRINALIN is azatadine maleate; pseudoephedrine sulfate. There are two drug master file entries for this compound. Additional details are available on the azatadine maleate; pseudoephedrine sulfate profile page.

Summary for TRINALIN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	49
Formulation / Manufacturing:	see details
DailyMed Link:	TRINALIN at DailyMed

Drug patent expirations by year for TRINALIN

Anatomical Therapeutic Chemical (ATC) Classes for TRINALIN

C01CA	Adrenergic and dopaminergic agents
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

R01AA	Sympathomimetics, plain
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01	NASAL PREPARATIONS
R	Respiratory system

R01AB	Sympathomimetics, combinations excl. corticosteroids
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01	NASAL PREPARATIONS
R	Respiratory system

R01BA	Sympathomimetics
R01B	NASAL DECONGESTANTS FOR SYSTEMIC USE
R01	NASAL PREPARATIONS
R	Respiratory system

R03CA	Alpha- and beta-adrenoreceptor agonists
R03C	ADRENERGICS FOR SYSTEMIC USE
R03	DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R	Respiratory system

R06AX	Other antihistamines for systemic use
R06A	ANTIHISTAMINES FOR SYSTEMIC USE
R06	ANTIHISTAMINES FOR SYSTEMIC USE
R	Respiratory system

S01FB	Sympathomimetics excl. antiglaucoma preparations
S01F	MYDRIATICS AND CYCLOPLEGICS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for TRINALIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Schering	TRINALIN	azatadine maleate; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	018506-001	Mar 23, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TRINALIN

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Schering	TRINALIN	azatadine maleate; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	018506-001	Mar 23, 1982	⤷ Try a Trial	⤷ Try a Trial
Schering	TRINALIN	azatadine maleate; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	018506-001	Mar 23, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for TRINALIN

See the table below for patents covering TRINALIN around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Italy	1123902	INTERMEDI AZA DIBENZOCICLOEPTENI E LORO PREPARAZIONE	⤷ Try a Trial
Switzerland	544091	Verfahren zur Herstellung von 5-substituierten Aza-dibenzo-cycloheptenen	⤷ Try a Trial
Brazil	6458580		⤷ Try a Trial
Norway	134157		⤷ Try a Trial
Cyprus	543	5-Substituted aza-dibenzo-cycloheptenes and the preparation thereof	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for TRINALIN

Anatomical Therapeutic Chemical (ATC) Classes for TRINALIN

Make Better Decisions: Try a trial or see plans & pricing